WallStreetZenWallStreetZen

NASDAQ: QNRX
Quoin Pharmaceuticals Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for QNRX

Based on 2 analysts offering 12 month price targets for Quoin Pharmaceuticals Ltd

Min Forecast
$20.00+309.84%
Avg Forecast
$25.00+412.3%
Max Forecast
$30.00+514.75%

Should I buy or sell QNRX stock?

Based on 2 analysts offering ratings for Quoin Pharmaceuticals Ltd.

Strong Buy
Strong Buy
2 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their QNRX stock forecasts and price targets.

QNRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-09-23
lockedlocked$00.00+00.00%2026-05-04

1 of 1

Forecast return on equity

Is QNRX forecast to generate an efficient return?

Company
N/A
Industry
20.62%
Market
168.94%

Forecast return on assets

Is QNRX forecast to generate an efficient return on assets?

Company
N/A
Industry
22.47%

QNRX earnings per share forecast

What is QNRX's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$6.67
Avg 2 year Forecast
-$2.88
Avg 3 year Forecast
-$1.79

QNRX revenue forecast

What is QNRX's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$32.1M

QNRX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
QNRX$4.88$25.00+412.30%Strong Buy
CLRB$1.82$10.00+449.45%Strong Buy
TVRD$1.28$7.33+472.89%Buy
DYAI$0.47N/AN/A
LPCN$2.16$4.00+85.19%Hold
View Top Biotech Stocks

Quoin Pharmaceuticals Stock Forecast FAQ

Is Quoin Pharmaceuticals Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: QNRX) stock is to Strong Buy QNRX stock.

Out of 2 analysts, 2 (100%) are recommending QNRX as a Strong Buy, 0 (0%) are recommending QNRX as a Buy, 0 (0%) are recommending QNRX as a Hold, 0 (0%) are recommending QNRX as a Sell, and 0 (0%) are recommending QNRX as a Strong Sell.

If you're new to stock investing, here's how to buy Quoin Pharmaceuticals stock.

What is QNRX's earnings growth forecast for 2026-2028?

(NASDAQ: QNRX) Quoin Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.99%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31.86%.

Quoin Pharmaceuticals's earnings in 2026 is -$18,665,315.On average, 6 Wall Street analysts forecast QNRX's earnings for 2026 to be -$468,562,815, with the lowest QNRX earnings forecast at -$543,532,022, and the highest QNRX earnings forecast at -$321,070,654. On average, 5 Wall Street analysts forecast QNRX's earnings for 2027 to be -$202,434,432, with the lowest QNRX earnings forecast at -$306,554,816, and the highest QNRX earnings forecast at -$141,713,944.

In 2028, QNRX is forecast to generate -$125,834,390 in earnings, with the lowest earnings forecast at -$153,621,852 and the highest earnings forecast at -$94,475,963.

What is QNRX's revenue growth forecast for 2026-2028?

(NASDAQ: QNRX) Quoin Pharmaceuticals's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 30.38%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.91%.

Quoin Pharmaceuticals's revenue in 2026 is $0.On average, 6 Wall Street analysts forecast QNRX's revenue for 2026 to be $0, with the lowest QNRX revenue forecast at $0, and the highest QNRX revenue forecast at $0. On average, 5 Wall Street analysts forecast QNRX's revenue for 2027 to be $0, with the lowest QNRX revenue forecast at $0, and the highest QNRX revenue forecast at $0.

In 2028, QNRX is forecast to generate $2,253,926,535 in revenue, with the lowest revenue forecast at $952,421,739 and the highest revenue forecast at $3,619,961,789.

What is QNRX's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: QNRX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 22.47%.

What is QNRX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year QNRX price target, the average QNRX price target is $25.00, with the highest QNRX stock price forecast at $30.00 and the lowest QNRX stock price forecast at $20.00.

On average, Wall Street analysts predict that Quoin Pharmaceuticals's share price could reach $25.00 by Sep 23, 2027. The average Quoin Pharmaceuticals stock price prediction forecasts a potential upside of 412.3% from the current QNRX share price of $4.88.

What is QNRX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: QNRX) Quoin Pharmaceuticals's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that QNRX's EPS will be -$6.67 for 2026, with the lowest EPS forecast at -$7.73, and the highest EPS forecast at -$4.57. On average, analysts forecast that QNRX's EPS will be -$2.88 for 2027, with the lowest EPS forecast at -$4.36, and the highest EPS forecast at -$2.02. In 2028, QNRX's EPS is forecast to hit -$1.79 (min: -$2.19, max: -$1.34).

What is QNRX's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: QNRX) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.